CF Foundation | National Annual Meeting: Impact of Trikafta on Advanced Lung Disease

Published on februari 9, 2021 by

During our first National Annual Meeting, Bruce Marshall, MD, our executive vice president and chief medical officer, shares how Trikafta has made an impact on people with cystic fibrosis who have advanced lung disease.

Originally recorded January 28, 2021.


Add your comment

Your email address will not be published.